Two Sigma Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $268K | Sell |
8,500
-24,800
| -74% | -$782K | ﹤0.01% | 2006 |
|
2025
Q1 | $1.09M | Buy |
33,300
+25,500
| +327% | +$835K | ﹤0.01% | 1436 |
|
2024
Q4 | $282K | Buy |
7,800
+1,000
| +15% | +$36.2K | ﹤0.01% | 2003 |
|
2024
Q3 | $212K | Sell |
6,800
-23,800
| -78% | -$742K | ﹤0.01% | 2043 |
|
2024
Q2 | $819K | Sell |
30,600
-112,700
| -79% | -$3.01M | ﹤0.01% | 1655 |
|
2024
Q1 | $4.89M | Sell |
143,300
-83,800
| -37% | -$2.86M | 0.01% | 789 |
|
2023
Q4 | $6.57M | Buy |
227,100
+31,000
| +16% | +$897K | 0.02% | 694 |
|
2023
Q3 | $5.41M | Sell |
196,100
-83,300
| -30% | -$2.3M | 0.01% | 692 |
|
2023
Q2 | $8.4M | Sell |
279,400
-30,300
| -10% | -$911K | 0.02% | 564 |
|
2023
Q1 | $11.2M | Buy |
309,700
+93,700
| +43% | +$3.39M | 0.03% | 520 |
|
2022
Q4 | $7.7M | Buy |
216,000
+118,700
| +122% | +$4.23M | 0.02% | 595 |
|
2022
Q3 | $3.29M | Buy |
97,300
+83,000
| +580% | +$2.81M | 0.01% | 937 |
|
2022
Q2 | $414K | Sell |
14,300
-16,400
| -53% | -$475K | ﹤0.01% | 2003 |
|
2022
Q1 | $992K | Buy |
30,700
+8,400
| +38% | +$271K | ﹤0.01% | 1642 |
|
2021
Q4 | $650K | Buy |
22,300
+9,500
| +74% | +$277K | ﹤0.01% | 1778 |
|
2021
Q3 | $341K | Sell |
12,800
-74,000
| -85% | -$1.97M | ﹤0.01% | 2064 |
|
2021
Q2 | $2.67M | Sell |
86,800
-146,000
| -63% | -$4.5M | 0.01% | 1158 |
|
2021
Q1 | $6.1M | Buy |
232,800
+89,600
| +63% | +$2.35M | 0.02% | 768 |
|
2020
Q4 | $3.6M | Sell |
143,200
-99,500
| -41% | -$2.5M | 0.01% | 960 |
|
2020
Q3 | $5.06M | Sell |
242,700
-173,500
| -42% | -$3.62M | 0.01% | 764 |
|
2020
Q2 | $9.89M | Buy |
416,200
+36,400
| +10% | +$865K | 0.03% | 560 |
|
2020
Q1 | $6.83M | Buy |
379,800
+250,200
| +193% | +$4.5M | 0.03% | 612 |
|
2019
Q4 | $3.07M | Sell |
129,600
-300
| -0.2% | -$7.12K | 0.01% | 1032 |
|
2019
Q3 | $3.57M | Sell |
129,900
-199,300
| -61% | -$5.48M | 0.01% | 891 |
|
2019
Q2 | $10.9M | Buy |
329,200
+97,000
| +42% | +$3.21M | 0.03% | 560 |
|
2019
Q1 | $8.14M | Buy |
+232,200
| New | +$8.14M | 0.02% | 669 |
|
2018
Q3 | – | Sell |
-11,600
| Closed | -$694K | – | 2389 |
|
2018
Q2 | $694K | Buy |
11,600
+4,600
| +66% | +$275K | ﹤0.01% | 1782 |
|
2018
Q1 | $321K | Buy |
+7,000
| New | +$321K | ﹤0.01% | 1982 |
|
2017
Q3 | – | Sell |
-18,400
| Closed | -$793K | – | 2345 |
|
2017
Q2 | $793K | Buy |
18,400
+200
| +1% | +$8.62K | ﹤0.01% | 1625 |
|
2017
Q1 | $570K | Buy |
18,200
+300
| +2% | +$9.4K | ﹤0.01% | 1837 |
|
2016
Q4 | $452K | Buy |
17,900
+1,700
| +10% | +$42.9K | ﹤0.01% | 1922 |
|
2016
Q3 | $401K | Buy |
+16,200
| New | +$401K | ﹤0.01% | 1768 |
|
2015
Q2 | – | Sell |
-36,600
| Closed | -$442K | – | 2059 |
|
2015
Q1 | $442K | Buy |
+36,600
| New | +$442K | ﹤0.01% | 1406 |
|